Table 4 Adverse events during the observation period
From: Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression
Number (percentage) | |
|---|---|
Asymptomatic bradycardia | 2 (5) |
Symptomatic bradycardia | 0 (0) |
Increase in norepinephrine dosage | 9 (22.5) |
Decrease in cardiac index | 7 (17.5) |
Decrease in cardiac index and ScvO2 | 1 (2.5) |
Decrease in stroke volume index | 2 (5) |
Increase in milrinone dosage | 6 (15) |